Human pd-l1-binding immunoglobulins

Jo Van Ginderachter; Geert Raes; Nick Devoogdt; Marleen Keyaerts; Quentin Lecocq; Catarina Xavier; Karine Breckpot; Katrijn Broos; Jessica Bridoux

Human pd-l1-binding immunoglobulins

Jo Van Ginderachter (Inventor), Geert Raes (Inventor), Nick Devoogdt (Inventor), Marleen Keyaerts (Inventor), Quentin Lecocq (Inventor), Catarina Xavier (Inventor), Karine Breckpot (Inventor), Katrijn Broos (Inventor), Jessica Bridoux (Inventor)

Research output: Patent

Abstract

The invention relates to polypeptides, in particular polypeptides comprising an immunoglobulin domain, binding to human Programmed Death Ligand-1 (huPDL1) and to applications of such polypeptides such as for use as a medicament or for use as diagnostic agent, for example as an immunotracer.

Original language	English
Patent number	WO2019166622
Publication status	Published - 2019

Cite this

@misc{55d1ee10cfb34603ad2ecca5eaae5a08,

title = "Human pd-l1-binding immunoglobulins",

abstract = "The invention relates to polypeptides, in particular polypeptides comprising an immunoglobulin domain, binding to human Programmed Death Ligand-1 (huPDL1) and to applications of such polypeptides such as for use as a medicament or for use as diagnostic agent, for example as an immunotracer.",

author = "{Van Ginderachter}, Jo and Geert Raes and Nick Devoogdt and Marleen Keyaerts and Quentin Lecocq and Catarina Xavier and Karine Breckpot and Katrijn Broos and Jessica Bridoux",

year = "2019",

language = "English",

type = "Patent",

note = "WO2019166622",

}

TY - PAT

T1 - Human pd-l1-binding immunoglobulins

AU - Van Ginderachter, Jo

AU - Raes, Geert

AU - Devoogdt, Nick

AU - Keyaerts, Marleen

AU - Lecocq, Quentin

AU - Xavier, Catarina

AU - Breckpot, Karine

AU - Broos, Katrijn

AU - Bridoux, Jessica

PY - 2019

Y1 - 2019

N2 - The invention relates to polypeptides, in particular polypeptides comprising an immunoglobulin domain, binding to human Programmed Death Ligand-1 (huPDL1) and to applications of such polypeptides such as for use as a medicament or for use as diagnostic agent, for example as an immunotracer.

AB - The invention relates to polypeptides, in particular polypeptides comprising an immunoglobulin domain, binding to human Programmed Death Ligand-1 (huPDL1) and to applications of such polypeptides such as for use as a medicament or for use as diagnostic agent, for example as an immunotracer.

UR - https://worldwide.espacenet.com/patent/search/family/065576372/publication/WO2019166622A1?q=WO2019166622

M3 - Patent

M1 - WO2019166622

ER -

Human pd-l1-binding immunoglobulins

Abstract

Other files and links

Fingerprint

IOF3036: INTEGRAL - Integrating a multimodal approach to address current challenges in immunotherapy

SRP50: SRP-Onderzoekszwaartepunt: Exploiting Peptides: Protein Binders, Modulators and Inhibitors for Imaging and Therapy [Exploit-PeptIT]

Cite this

Human pd-l1-binding immunoglobulins

Abstract

Other files and links

Fingerprint

Projects

IOF3036: INTEGRAL - Integrating a multimodal approach to address current challenges in immunotherapy

SRP50: SRP-Onderzoekszwaartepunt: Exploiting Peptides: Protein Binders, Modulators and Inhibitors for Imaging and Therapy [Exploit-PeptIT]

Cite this